univariate | multivariate | ||||||
---|---|---|---|---|---|---|---|
variables | OR | 95%C.I. | P-value | OR | 95%C.I. | P-value | |
IMRT (reference) vs. BT | 9.840 | 5.681–17.041 | <0.001 | 5.032 | 1.911–13.253 | 0.001 | |
PSA | -10 ng/mL | reference | n.s. | ||||
10-20 ng/mL | 0.766 | 0.459–1.277 | 0.306 | ||||
20 ng/mL- | 0.202 | 0.096–0.426 | <0.001 | ||||
BED | -160Gy2 | reference | reference | ||||
160-180Gy2 | 7.040 | 3.546–13.977 | <0.001 | 2.753 | 1.017–7.450 | 0.046 | |
180Gy2- | 8.038 | 4.800–13.459 | <0.001 | 2.859 | 1.184–6.903 | 0.020 | |
Age | −64 | reference | reference | ||||
65–74 | 1.666 | 1.017–2.730 | 0.043 | 2.679 | 1.524–4.709 | 0.001 | |
75- | 1.498 | 0.819–2.742 | 0.190 | 2.956 | 1.444–6.053 | 0.003 | |
Risk (D’Amico) | Low | reference | n.s. | ||||
Intermediate | 0.982 | 0.604–1.597 | 0.941 | ||||
High | 0.445 | 0.255–0.778 | 0.004 | ||||
ADT use | none | reference | n.s. | ||||
Neoad+ | 0.729 | 0.450–1.183 | 0.201 | ||||
Ad+ | 0.290 | 0.070–1.197 | 0.087 | ||||
Neoad+/Ad+ | 0.326 | 0.175–0.610 | <0.001 |